MIT-made COVID-19 vax produced by yeast could address global vaccine inequitynews2022-03-16T15:18:56+00:00March 16th, 2022|FierceBiotech|
FDA’s gene editing guidance is ‘par for the course’ but still important, analysts saynews2022-03-16T13:43:11+00:00March 16th, 2022|FierceBiotech|
With clinical holds lifted, Aprea embarks on ‘show me’ year for key cancer candidatenews2022-03-16T13:12:04+00:00March 16th, 2022|FierceBiotech|
Sanofi steps off the sidelines to ink 3 ADC deal with Seagen, reigniting long-held interest in the modality news2022-03-16T11:29:20+00:00March 16th, 2022|FierceBiotech|
Biogen jettisons AMD drug, providing Catalyst for ex-partner’s hunt for strategic alternativesnews2022-03-16T08:11:14+00:00March 16th, 2022|FierceBiotech|
With $987M round, Frazier looks to form several new biotechs this year, bankroll othersnews2022-03-15T20:04:34+00:00March 15th, 2022|FierceBiotech|
Belgian biotech Precirix snags $88M to bankroll radiopharmaceuticals in HER2-positive cancersnews2022-03-15T19:01:13+00:00March 15th, 2022|FierceBiotech|
Unlocking the power of AI-driven pathology in drug development: An Interview with Bristol Myers Squibbnews2022-03-15T18:19:21+00:00March 15th, 2022|FierceBiotech|
Ovid finds new focus in epilepsy but trims staff to extend cash runwaynews2022-03-15T18:12:27+00:00March 15th, 2022|FierceBiotech|
Zai Lab hires ex-Lilly CFO who departed after investigation found ‘inappropriate’ behaviornews2022-03-15T15:23:00+00:00March 15th, 2022|FierceBiotech|
